Aegis Sciences Corporation Acquires HealthTrackRx’s Toxicology Business Unit
Aegis Sciences Corporation, today announced its acquisition of the HealthTrackRx Toxicology line of business.
READ PRESS RELEASE
HealthTrackRx Opens Louisville Area Lab to Deliver Next-Morning PCR Results Nationwide
HealthTrackRx selected the Greater Louisville Region to serve its growing nationwide customer base because of its proximity to UPS.
READ PRESS RELEASE
HealthTrackRx to Present Study Results at IDWeek 2022
A comparative analysis of the detection of UTI pathogens via culture method and the Open Array ®-nanofluidic real-time PCR method.
READ PRESS RELEASE
HealthTrackRx to Expand with Site in Clarksville
Southern Indiana continues to expand its presence in the medical technology industry as HealthTrackRx, announces plans for a 10,000 sq. ft. facility in Clarksville.
READ PRESS RELEASE
HealthTrackRx Develops the First Nationwide Commercially Available Monkeypox-specific PCR Test with Next-day Results
The test was developed by the company’s research and development team and is available to the thousands of HealthTrackRx customers.
READ PRESS RELEASE
HealthTrackRx Partners with the CDC to Study Monkeypox in the U.S.
HealthTrackRx is working with the CDC to conduct an epidemiologic study to understand how widespread Monkeypox is within the United States.
READ PRESS RELEASE
HealthTrackRx Opens Regional PCR Laboratory in Georgia
HealthTrackRx selected the Atlanta market to serve its growing customer base throughout the Southeast.
READ PRESS RELEASE
HealthTrackRx Offers a Menu of Testing Options for Respiratory Pathogens to Help Clinicians Get to the Right Answers Faster
With HealthTrackRx PCR testing, clinicians can select from a variety of menus, four of which include testing for COVID-19.
READ PRESS RELEASE
HealthTrackRx Retains FDA Emergency Use Authorization for COVID-19 Testing
HealthTrackRx is one of only 27 labs nationwide permitted to use the LDT COVID-19 Test under the FDA EUA.
READ PRESS RELEASE
HealthTrackRx Confirms Its PCR Testing Technology Detects COVID-19 Caused by the Omicron Variant
HealthTrackRx confirmed that its proprietary testing technology is able to detect the presence of SARS-CoV-2 even with the emerging B.1.1.529 or Omicron variant.
READ PRESS RELEASE